{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:10:43Z","timestamp":1783012243774,"version":"3.54.6"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":154,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["201591\/2012-0"],"award-info":[{"award-number":["201591\/2012-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1111\/bjd.13586","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T07:16:16Z","timestamp":1418454976000},"page":"1420-1423","source":"Crossref","is-referenced-by-count":18,"title":["Rituximab therapy in pemphigus foliaceus: report of 12 cases and review of recent literature"],"prefix":"10.1093","volume":"172","author":[{"given":"L.","family":"de Sena Nogueira Maehara","sequence":"first","affiliation":[{"name":"Centre for Blistering Diseases; Department of Dermatology; University Medical Centre Groningen; University of Groningen; Hanzeplein 1 9700 RB Groningen the Netherlands"},{"name":"Department of Dermatology; Federal University of S\u00e3o Paulo; S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Huizinga","sequence":"additional","affiliation":[{"name":"Centre for Blistering Diseases; Department of Dermatology; University Medical Centre Groningen; University of Groningen; Hanzeplein 1 9700 RB Groningen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Jonkman","sequence":"additional","affiliation":[{"name":"Centre for Blistering Diseases; Department of Dermatology; University Medical Centre Groningen; University of Groningen; Hanzeplein 1 9700 RB Groningen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,31]]},"reference":[{"key":"10.1111\/bjd.13586-BIB0001|bjd13586-cit-0001","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2133.2011.10663.x","article-title":"Low-dose rituximab is effective in pemphigus","volume":"166","author":"Horvath","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13586-BIB0002|bjd13586-cit-0002","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12026-013-8411-1","article-title":"Refractory pemphigus foliaceus and Beh\u00e7et's disease successfully treated with tocilizumab","volume":"56","author":"Caso","year":"2013","journal-title":"Immunol Res"},{"key":"10.1111\/bjd.13586-BIB0003|bjd13586-cit-0003","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1590\/abd1806-4841.20131905","article-title":"Off-label use of rituximab in dermatology: pemphigus treatment","volume":"88","author":"Bomm","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1111\/bjd.13586-BIB0004|bjd13586-cit-0004","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2340\/00015555-1746","article-title":"First-line combination therapy with rituximab and corticosteroids is effective and safe for pemphigus","volume":"94","author":"Cho","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.13586-BIB0005|bjd13586-cit-0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00403-013-1355-4","article-title":"A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximab","volume":"306","author":"Leshem","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.13586-BIB0006|bjd13586-cit-0006","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4103\/0378-6323.140301","article-title":"Use of rituximab in pemphigus patients with chronic viral hepatitis: report of three cases","volume":"80","author":"Kanwar","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/bjd.13586-BIB0007|bjd13586-cit-0007","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/0378-6323.136832","article-title":"Intermediate doses of rituximab used as adjuvant therapy in refractory pemphigus","volume":"80","author":"Londhe","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/bjd.13586-BIB0008|bjd13586-cit-0008","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaad.2014.05.071","article-title":"Successful use of rituximab in the treatment of childhood and juvenile pemphigus","volume":"71","author":"Vinay","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13586-BIB0009|bjd13586-cit-0009","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/bjd.12972","article-title":"Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study","volume":"170","author":"Kanwar","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13586-BIB0010|bjd13586-cit-0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000357031","article-title":"Pilot study of 19 patients with severe pemphigus: prophylactic treatment with rituximab does not appear to be beneficial","volume":"228","author":"Gregoriou","year":"2014","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13586-BIB0011|bjd13586-cit-0011","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2011.11.007","article-title":"Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up","volume":"67","author":"Cianchini","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13586-BIB0012|bjd13586-cit-0012","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jamadermatol.2013.6739","article-title":"Durable remission of pemphigus with a fixed-dose rituximab protocol","volume":"150","author":"Heelan","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.13586-BIB0013|bjd13586-cit-0013","doi-asserted-by":"crossref","first-page":"175ra30","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1111\/bjd.13586-BIB0014|bjd13586-cit-0014","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1532-5415.2012.03987.x","article-title":"Pemphigus in elderly adults: clinical presentation, treatment, and prognosis","volume":"60","author":"Ingen-Housz-Oro","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/bjd.13586-BIB0015|bjd13586-cit-0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jdv.12080","article-title":"Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities","volume":"28","author":"Cho","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13586-BIB0016|bjd13586-cit-0016","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/jdv.12175","article-title":"Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication","volume":"28","author":"Kolesnik","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13586-BIB0017|bjd13586-cit-0017","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaad.2012.08.010","article-title":"Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients","volume":"68","author":"Leshem","year":"2013","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13586","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13586\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:13:12Z","timestamp":1676383992000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/172\/5\/1420\/6616220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,31]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13586","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3,31]]}}}